National Center for Disease Control: Chikungunya and Dengue Fever with Thrombocytopenia Syndrome Included in Category B Infectious Disease Management

K-LinePoet · 2026-03-28T10:19:40+00:00

The National Center for Disease Control held a press conference, announcing that chikungunya fever and dengue fever with thrombocytopenia syndrome have been classified as Category B infectious diseases to strengthen epidemic prevention and to standardize prevention and control measures, with a focus on enhancing monitoring and early warning, guidance, prevention and control, and science popularization efforts.

K-LinePoet

2026-03-28 10:19:40

Abstract generation in progress

The National Health Commission held a press conference today to report on the recent analysis of key infectious disease epidemic situations and health risk alerts. Liu Qing, deputy director of the Infectious Disease Control Department of the National Health Commission, introduced that yesterday, China announced the inclusion of Chikungunya fever and Thrombocytopenia syndrome as Class B infectious diseases for management. There are two main considerations for this adjustment: first, to strengthen the prevention and response to the epidemic risk; second, to promote a more scientific and standardized approach to prevention and control work. After Chikungunya fever and Thrombocytopenia syndrome are included in the management of Class B statutory infectious diseases, we will further improve relevant prevention and control policies and measures. First, strengthen monitoring and early warning; second, enhance prevention and control guidance; third, widely promote patriotic health campaigns; fourth, strengthen popular science education. (CCTV News)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes